- recruitingHuman Pharmacology (Phase I)- First administration to humans
A clinical study of the V540A vaccine in healthy adults (V540A-001)
This study is testing a new vaccine called V540A for Human Papillomavirus (HPV) in healthy adults. It's the first time this vaccine is being given to people. Researchers want to see if it's safe and how it works in the body.
Belgium - recruiting
Impact of Human Papillomavirus Carriage on IVF/ICSI Results (HPV AMP)
This study looks at how the Human Papillomavirus (HPV) might affect the success of IVF treatments for women. It aims to see if having HPV impacts getting pregnant through IVF, which could encourage more people to get the HPV vaccine.
France - recruiting
HPV Equity Study: Exploring Cervical Cancer Control in Scotland for Women With Experience of Priority Risks
This study in Scotland looks at how best to offer the HPV vaccine to women aged 25-45 who may be at higher risk of cervical cancer. It aims to improve vaccination rates and understand people's experiences.
United Kingdom